The Body: The Complete HIV/AIDS Resource
Sign up for free e-mail updates!The Body en Espanol
Please Note: Due to volume considerations, not all questions can be answered. Questions most likely to be answered will be those of general interest to a broad group of visitors to this forum. Questions pertaining to a specific case; requests for diagnosis, medical advice, or second opinion; or requests for opinions about untested alternative therapies will generally not be answered.

The participation of Dr. Renslow Sherer in this Forum is made possible in part by an unrestricted educational grant from Abbott Laboratories.

Ask the Experts about Drug Resistance and Staying Undetectable
Recent AnswersAsk a Question

 

Phase III Study of TMC114 TMC125
Mar 15, 2006

Dr.Sherer,

I have been HIV+ since 1992 & have been on almost every medication since that time. I am now resistant to all the current drugs & have also failed on the Tipranivir study. My question is whether I should try the new Duet trials which are starting soon. I am worried that if I only get the TMC114 & not the TMC125 in the trial that I will become resistant to the 114. I know that there is a small group already getting the 2 together and they have had promising results so far. My CD4 are 290 & viral load at 84000 so I am wondering if it might be better to wait until the 2 are available together for compassionate use. Would appreciate any input you might have.

Thank you.

HH

Response from Dr. Sherer

These are the hardest types of questions to answer, because the information I would need from you in order to give you the best possible answer is difficult to convey in a single email. I would urge you to take this question and this response to your doctor, and discuss it with him or her.

In general, I would agree with your concern that you may not receive both drugs simply by enrolling in the trial. You already can access TMC-114 by compassionate access, so the question is, how long can you afford to wait for TMC125 or another second line NNRTI - or, for that matter, a next generation NRTI or entry inhibitor?

The answer to this question is highly variable and dependent on your individual treatment history, the specific mutational patterns that you harbor, and your recent treatment history and recent viral loads and CD4 cell counts, in particular for the past 2 years. I would like to know the recent trends in your CD4 cell count (stable, drifting downwards, or falling rapidly), and in the most recent resistant tests (i.e. are there multiple new mutations? or a stable group?) This is why the answers are so variable.



Terms of Use
Please remember that this forum is designed for educational purposes only, and experts are not engaged through this forum in rendering legal or medical advice or professional services. Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither The Body nor any sponsor is the publisher or speaker of posted visitors' questions or the experts' material.

Questions and messages posted to this forum are not statements of advice, opinion, or information of The Body, Body Health Resources Corporation or any sponsor of this forum. While neither The Body nor Body Health Resources Corporation regularly reviews posted content, we reserve the right to delete, move, or edit postings if we deem it appropriate under the circumstances. Visitors submitting questions remain solely responsible for the content of their messages.

Information provided by experts is general only and should not be used for diagnosing or treating a health problem or a disease, or relied upon as legal or other professional advice. This information is not a substitute for professional advice or care. If you have or suspect you may have a health or legal problem, you should consult your own health care provider or your attorney.

Copyright notice.